EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C30H24N4O8 |
| Net Charge | 0 |
| Average Mass | 568.542 |
| Monoisotopic Mass | 568.15941 |
| SMILES | CCOc1nc2cccc(C(=O)OCc3oc(=O)oc3C)c2n1Cc1ccc(-c2ccccc2-c2noc(=O)n2)cc1 |
| InChI | InChI=1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36) |
| InChIKey | QJFSABGVXDWMIW-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Role: | angiotensin receptor antagonist A hormone antagonist that blocks angiotensin receptors. |
| Applications: | prodrug A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. angiotensin receptor antagonist A hormone antagonist that blocks angiotensin receptors. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| azilsartan medoxomil (CHEBI:68845) has functional parent azilsartan (CHEBI:68850) |
| azilsartan medoxomil (CHEBI:68845) has role angiotensin receptor antagonist (CHEBI:61016) |
| azilsartan medoxomil (CHEBI:68845) has role antihypertensive agent (CHEBI:35674) |
| azilsartan medoxomil (CHEBI:68845) has role prodrug (CHEBI:50266) |
| azilsartan medoxomil (CHEBI:68845) is a 1,2,4-oxadiazole (CHEBI:46809) |
| azilsartan medoxomil (CHEBI:68845) is a aromatic ether (CHEBI:35618) |
| azilsartan medoxomil (CHEBI:68845) is a benzimidazoles (CHEBI:22715) |
| azilsartan medoxomil (CHEBI:68845) is a carboxylic ester (CHEBI:33308) |
| azilsartan medoxomil (CHEBI:68845) is a cyclic carbonate ester (CHEBI:46838) |
| azilsartan medoxomil (CHEBI:68845) is a dioxolane (CHEBI:39430) |
| azilsartan medoxomil (CHEBI:68845) is conjugate acid of azilsartan medoxomil(1−) (CHEBI:68849) |
| Incoming Relation(s) |
| azilsartan medoxomil(1−) (CHEBI:68849) is conjugate base of azilsartan medoxomil (CHEBI:68845) |
| IUPAC Name |
|---|
| (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1-benzimidazole-7-carboxylate |
| INNs | Source |
|---|---|
| azilsartan medoxomil | WHO MedNet |
| azilsartan médoxomil | WHO MedNet |
| azilsartán medoxomilo | WHO MedNet |
| azilsartanum medoxomilum | WHO MedNet |
| Brand Name | Source |
|---|---|
| Edarbi | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 4322 | DrugCentral |
| Azilsartan | Wikipedia |
| D08067 | KEGG DRUG |
| US2005187269 | Patent |
| Registry Numbers | Sources |
|---|---|
| Reaxys:12326818 | Reaxys |
| CAS:863031-21-4 | KEGG DRUG |
| CAS:863031-21-4 | ChemIDplus |
| Citations |
|---|